Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TurkCure is a Turkish biotechnology company specializing in the development and manufacturing of advanced therapy medicinal products (ATMPs), with a primary focus on CAR-T cell therapies. Founded by leading scientists in the field of hematology, the company aims to provide localized and affordable access to cutting-edge cancer treatments in the Middle East and Eastern Europe. TurkCure operates sophisticated research and GMP manufacturing facilities in Istanbul, targeting various hematological malignancies such as leukemia and lymphoma. The company is a pioneer in the Turkish biotech ecosystem, leveraging clinical expertise to move programs through early-stage development. Their mission centers on reducing the high costs associated with personalized cell therapies to improve patient reach.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TurkCure.